2023
PD29-01 THE HEMATURIA CANCER RISK SCORE: A VALIDATION STUDY DEMONSTRATING REDUCTION IN THE NUMBER NEEDED TO INVESTIGATE WHILE PRESERVING FIDELITY OF CANCER DETECTION
Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. PD29-01 THE HEMATURIA CANCER RISK SCORE: A VALIDATION STUDY DEMONSTRATING REDUCTION IN THE NUMBER NEEDED TO INVESTIGATE WHILE PRESERVING FIDELITY OF CANCER DETECTION. Journal Of Urology 2023, 209: e824. DOI: 10.1097/ju.0000000000003315.01.Peer-Reviewed Original ResearchA0269 The hematuria cancer risk score: A validation study demonstrating reduction in the number needed to investigate while preserving fidelity of cancer detection
Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. A0269 The hematuria cancer risk score: A validation study demonstrating reduction in the number needed to investigate while preserving fidelity of cancer detection. European Urology 2023, 83: s385-s386. DOI: 10.1016/s0302-2838(23)00318-4.Peer-Reviewed Original Research
2019
182 Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer
Tan W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Hermanns T, Waisbrod S, Sasieni P, Kelly J. 182 Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer. European Urology Open Science 2019, 18: e247-e249. DOI: 10.1016/s1569-9056(19)30179-4.Peer-Reviewed Original Research